Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UIZFH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
XB3-001
|
|||||
| Synonyms |
Melanotransferrin-trastuzumab conjugate (biOasis); MTf-TZM; MTfp-TZM; p97-trastuzumab conjugate (T)
Click to Show/Hide
|
|||||
| Organization |
Bioasis Technologies, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||